On December 8, 2022 Nanology reported that it will be attending the following conference (Press release, NanOlogy, DEC 7, 2022, View Source;utm_medium=rss&utm_campaign=jan-9-13-jp-morgan-41st-annual-healthcare-conference-san-francisco [SID1234624956]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

JP Morgan 41st Annual Healthcare Conference
Event: JP Morgan 41st Annual Healthcare Conference
Dates: January 9-11, 2023
Location: San Francisco

NanOlogy representatives will be in San Francisco January 9-11 for JPM/Biotech Showcase Week. Email [email protected] if you would like to schedule a meeting or contact us through the Biotech Showcase Partnering Platform. NanOlogy is a clinical-stage oncology company with a proprietary particle engineering technology that forms patented large surface area microparticles (LSAMS) of pure drug for solid tumor-directed delivery to maximize drug in the tumor and minimize systemic toxicity. Clinical trials in multiple solid tumors (pancreas, lung, bladder, prostate, ovarian, peritoneal) across more than 170 patients to date have demonstrated promising tumor response and immunomodulation with minimal toxicity.